Gene · 2355
Papers2,749
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 2,749
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The long non-coding RNA TAZ-AS202 promotes lung cancer progression via regulation of the E2F1 transcription factor and activation of Ephrin signaling. | Cell Death Dis | 2023 | 37980331 | PubTator, text mining | PubMed |
| Crosstalk and plasticity driving between cancer-associated fibroblasts and tumor microenvironment: significance of breast cancer metastasis. | J Transl Med | 2023 | 37978384 | PubTator, text mining | PubMed |
| Molecular profiling of clinical remission in psoriatic arthritis reveals dysregulation of FOS and CCDC50 genes: a gene expression study. | Front Immunol | 2023 | 37965313 | PubTator, text mining | PubMed |
| New Potentiality of Bioactive Substances: Regulating the NLRP3 Inflammasome in Autoimmune Diseases. | Nutrients | 2023 | 37960237 | PubTator, text mining | PubMed |
| Aging-related genes revealed Neuroinflammatory mechanisms in ischemic stroke by bioinformatics. | Heliyon | 2023 | 37954339 | PubTator, text mining | PubMed |
| KYNU as a Biomarker of Tumor-Associated Macrophages and Correlates with Immunosuppressive Microenvironment and Poor Prognosis in Gastric Cancer. | Int J Genomics | 2023 | 37954130 | PubTator, text mining | PubMed |
| Candidate biomarkers for treatment benefit from sunitinib in patients with advanced renal cell carcinoma using mass spectrometry-based (phospho)proteomics. | Clin Proteomics | 2023 | 37940875 | PubTator, text mining | PubMed |
| Discordance between chromatin accessibility and transcriptional activity during the human primed-to-naïve pluripotency transition process. | Cell Regen | 2023 | 37938437 | PubTator, text mining | PubMed |
| Temporally specific gene expression and chromatin remodeling programs regulate a conserved Pdyn enhancer. | Elife | 2023 | 37938195 | PubTator, text mining | PubMed |
| A tissue-engineered model of the blood-tumor barrier during metastatic breast cancer. | Fluids Barriers CNS | 2023 | 37924145 | PubTator, text mining | PubMed |
| Investigating the Molecular Mechanisms Underlying Early Response to Inflammation and Helicobacter pylori Infection in Human Gastric Epithelial Cells. | Int J Mol Sci | 2023 | 37894827 | PubTator, text mining | PubMed |
| Role and mechanism of PVN-sympathetic-adipose circuit in depression and insulin resistance induced by chronic stress. | EMBO Rep | 2023 | 37870400 | PubTator, text mining | PubMed |
| Identification of the regulatory circuit governing corneal epithelial fate determination and disease. | PLoS Biol | 2023 | 37856539 | PubTator, text mining | PubMed |
| Characterization of human transcription factor function and patterns of gene regulation in HepG2 cells. | Genome Res | 2023 | 37852782 | PubTator, text mining | PubMed |
| Single-cell chromatin accessibility and transcriptomic characterization of Behcet's disease. | Commun Biol | 2023 | 37848613 | PubTator, text mining | PubMed |
| The Role of Non-Coding RNAs in Myelodysplastic Neoplasms. | Cancers (Basel) | 2023 | 37835504 | PubTator, text mining | PubMed |
| Genome-Wide Characterization of TAZ Binding Sites in Mammary Epithelial Cells. | Cancers (Basel) | 2023 | 37835407 | PubTator, text mining | PubMed |
| The Mechanism of Interleukin 33-Induced Stimulation of Interleukin 6 in MLO-Y4 Cells. | Int J Mol Sci | 2023 | 37834290 | PubTator, text mining | PubMed |
| Overexpression of FRA1 (FOSL1) Leads to Global Transcriptional Perturbations, Reduced Cellular Adhesion and Altered Cell Cycle Progression. | Cells | 2023 | 37830558 | PubTator, text mining | PubMed |
| MUC1-C intersects chronic inflammation with epigenetic reprogramming by regulating the set1a compass complex in cancer progression. | Commun Biol | 2023 | 37821650 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2355/papers?page=12